• Je něco špatně v tomto záznamu ?

Geographic variation of mutagenic exposures in kidney cancer genomes

S. Senkin, S. Moody, M. Díaz-Gay, B. Abedi-Ardekani, T. Cattiaux, A. Ferreiro-Iglesias, J. Wang, S. Fitzgerald, M. Kazachkova, R. Vangara, AP. Le, EN. Bergstrom, A. Khandekar, B. Otlu, S. Cheema, C. Latimer, E. Thomas, JR. Atkins, K. Smith-Byrne,...

. 2024 ; 629 (8013) : 910-918. [pub] 20240501

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014060

Grantová podpora
Wellcome Trust - United Kingdom
001 World Health Organization - International

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden1. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence2. Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations. Here we sequenced 962 clear cell renal cell carcinomas from 11 countries with varying incidence. The somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures characteristic of aristolochic acid compounds were present in most cases, but these were rare elsewhere. In Japan, a mutational signature of unknown cause was found in more than 70% of cases but in less than 2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher incidence rates of kidney cancer. Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension, suggesting that non-mutagenic mechanisms of action underlie these risk factors. The results of this study indicate the existence of multiple, geographically variable, mutagenic exposures that potentially affect tens of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.

Bevital AS Bergen Norway

Biomedical Sciences Graduate Program University of California San Diego La Jolla CA USA

Cancer Ageing and Somatic Mutation Wellcome Sanger Institute Cambridge UK

Cancer Epidemiology Unit The Nuffield Department of Population Health University of Oxford Oxford UK

Cancer Research UK Edinburgh Centre Institute of Genetics and Cancer University of Edinburgh Edinburgh UK

Centre for Biodiversity Genomics University of Guelph Guelph Ontario Canada

Clinic of Nephrology Faculty of Medicine Military Medical Academy Belgrade Serbia

Department of Anatomic Pathology A C Camargo Cancer Center São Paulo Brazil

Department of Bioengineering University of California San Diego La Jolla CA USA

Department of Botany and Genetics Institute of Biosciences Vilnius University Vilnius Lithuania

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno Czech Republic

Department of Cellular and Molecular Medicine University of California San Diego La Jolla CA USA

Department of Clinical Epidemiology N N Blokhin National Medical Research Centre of Oncology Moscow Russia

Department of Environmental Epidemiology Nofer Institute of Occupational Medicine Łódź Poland

Department of Epidemiology A C Camargo Cancer Center São Paulo Brazil

Department of Health Informatics Graduate School of Informatics Middle East Technical University Ankara Turkey

Department of Oncology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Pathology Barretos Cancer Hospital Barretos Brazil

Department of Pathology Graduate School of Medicine The University of Tokyo Bunkyo ku Japan

Department of Pathology Radboud University Medical Centre Nijmegen Netherlands

Department of Surgery Division of Urology Sao Paulo Federal University São Paulo Brazil

Department of Urology A C Camargo Cancer Center São Paulo Brazil

Department of Urology Barretos Cancer Hospital Barretos Brazil

Department of Urology N N Blokhin National Medical Research Centre of Oncology Moscow Russia

Department of Urology University Hospital Dr D Misovic Clinical Center Belgrade Serbia

Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville MD USA

Division of Cancer Genomics National Cancer Center Research Institute Chuo ku Japan

Division of Urology Department of Surgery Faculty of Medicine Prince of Songkla University Hat Yai Thailand

Evidence Synthesis and Classification Branch International Agency for Research on Cancer Lyon France

Experimental Research Center Genomic Medicine Laboratory Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Faculdade Ciências Médicas de Minas Gerais Belo Horizonte Brazil

Faculty of Health Sciences Palacky University Olomouc Czech Republic

Genomic Epidemiology Branch International Agency for Research on Cancer Lyon France

Hasheminejad Kidney Center Iran University of Medical Sciences Tehran Iran

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Public Health and Preventive Medicine 2nd Faculty of Medicine Charles University Prague Czech Republic

International Organization for Cancer Prevention and Research Belgrade Serbia

Laboratory of Genetic Diagnostic National Cancer Institute Vilnius Lithuania

Laboratory of Molecular Medicine The Institute of Medical Science The University of Tokyo Minato ku Japan

Latin American Renal Cancer Group São Paulo Brazil

Leeds Institute of Medical Research at St James's University of Leeds Leeds UK

Life and Health Sciences Research Institute School of Medicine Minho University Braga Portugal

Molecular Oncology Research Center Barretos Cancer Hospital Barretos Brazil

Moores Cancer Center University of California San Diego La Jolla CA USA

National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation A C Camargo Cancer Center São Paulo Brazil

Nutrition and Metabolism Branch International Agency for Research on Cancer Lyon France

Observational and Pragmatic Research Institute Pte Ltd Singapore Singapore

Occupational Health and Toxicology Department National Center for Environmental Risk Monitoring National Institute of Public Health Bucharest Romania

Oncopathology Research Center Iran University of Medical Sciences Tehran Iran

Ontario Tumour Bank Ontario Institute for Cancer Research Toronto Ontario Canada

Post Graduate Program in Genetics and Molecular Biology Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

Post Graduate Program in Medicine Surgical Sciences Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

Service d'Anatomie Pathologique Assistance Publique Hôpitaux de Paris Univeristé Paris Saclay Le Kremlin Bicêtre France

Service of Urology Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Translational Medicine Research Center Faculty of Medicine Prince of Songkla University Hat Yai Thailand

Transplant Immunology and Personalized Medicine Unit Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Urology Department Carol Davila University of Medicine and Pharmacy Prof Dr Th Burghele Clinical Hospital Bucharest Romania

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014060
003      
CZ-PrNML
005      
20240905133518.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41586-024-07368-2 $2 doi
035    __
$a (PubMed)38693263
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Senkin, Sergey $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France $1 https://orcid.org/000000015848005X
245    10
$a Geographic variation of mutagenic exposures in kidney cancer genomes / $c S. Senkin, S. Moody, M. Díaz-Gay, B. Abedi-Ardekani, T. Cattiaux, A. Ferreiro-Iglesias, J. Wang, S. Fitzgerald, M. Kazachkova, R. Vangara, AP. Le, EN. Bergstrom, A. Khandekar, B. Otlu, S. Cheema, C. Latimer, E. Thomas, JR. Atkins, K. Smith-Byrne, R. Cortez Cardoso Penha, C. Carreira, P. Chopard, V. Gaborieau, P. Keski-Rahkonen, D. Jones, JW. Teague, S. Ferlicot, M. Asgari, S. Sangkhathat, W. Attawettayanon, B. Świątkowska, S. Jarmalaite, R. Sabaliauskaite, T. Shibata, A. Fukagawa, D. Mates, V. Jinga, S. Rascu, M. Mijuskovic, S. Savic, S. Milosavljevic, JMS. Bartlett, M. Albert, L. Phouthavongsy, P. Ashton-Prolla, MR. Botton, B. Silva Neto, SM. Bezerra, MP. Curado, SC. Zequi, RM. Reis, EF. Faria, NS. de Menezes, RS. Ferrari, RE. Banks, NS. Vasudev, D. Zaridze, A. Mukeriya, O. Shangina, V. Matveev, L. Foretova, M. Navratilova, I. Holcatova, A. Hornakova, V. Janout, MP. Purdue, N. Rothman, SJ. Chanock, PM. Ueland, M. Johansson, J. McKay, G. Scelo, E. Chanudet, L. Humphreys, AC. de Carvalho, S. Perdomo, LB. Alexandrov, MR. Stratton, P. Brennan
520    9_
$a International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden1. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence2. Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations. Here we sequenced 962 clear cell renal cell carcinomas from 11 countries with varying incidence. The somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures characteristic of aristolochic acid compounds were present in most cases, but these were rare elsewhere. In Japan, a mutational signature of unknown cause was found in more than 70% of cases but in less than 2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher incidence rates of kidney cancer. Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension, suggesting that non-mutagenic mechanisms of action underlie these risk factors. The results of this study indicate the existence of multiple, geographically variable, mutagenic exposures that potentially affect tens of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a kyseliny aristolochové $x škodlivé účinky $7 D034341
650    12
$a karcinom z renálních buněk $x genetika $x epidemiologie $x chemicky indukované $7 D002292
650    12
$a vystavení vlivu životního prostředí $x škodlivé účinky $x analýza $7 D004781
650    _2
$a genom lidský $x genetika $7 D015894
650    _2
$a genomika $7 D023281
650    12
$a zeměpis $7 D005843
650    _2
$a hypertenze $x epidemiologie $7 D006973
650    _2
$a incidence $7 D015994
650    12
$a nádory ledvin $x genetika $x epidemiologie $x chemicky indukované $7 D007680
650    12
$a mutageny $x škodlivé účinky $7 D009153
650    12
$a mutace $7 D009154
650    _2
$a obezita $x epidemiologie $7 D009765
650    _2
$a rizikové faktory $7 D012307
650    _2
$a kouření tabáku $x škodlivé účinky $x genetika $7 D000073869
651    _2
$a Japonsko $x epidemiologie $7 D007564
651    _2
$a Rumunsko $x epidemiologie $7 D012383
651    _2
$a Srbsko $x epidemiologie $7 D055771
651    _2
$a Thajsko $x epidemiologie $7 D013785
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Moody, Sarah $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK $1 https://orcid.org/0000000349041041
700    1_
$a Díaz-Gay, Marcos $u Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA $u Department of Bioengineering, University of California San Diego, La Jolla, CA, USA $u Moores Cancer Center, University of California San Diego, La Jolla, CA, USA $1 https://orcid.org/0000000306580467
700    1_
$a Abedi-Ardekani, Behnoush $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Cattiaux, Thomas $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France $1 https://orcid.org/0000000248267965
700    1_
$a Ferreiro-Iglesias, Aida $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Wang, Jingwei $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK $1 https://orcid.org/0000000202012369
700    1_
$a Fitzgerald, Stephen $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK $1 https://orcid.org/0000000305854833
700    1_
$a Kazachkova, Mariya $u Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA $u Moores Cancer Center, University of California San Diego, La Jolla, CA, USA $u Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, USA
700    1_
$a Vangara, Raviteja $u Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA $u Department of Bioengineering, University of California San Diego, La Jolla, CA, USA $u Moores Cancer Center, University of California San Diego, La Jolla, CA, USA
700    1_
$a Le, Anh Phuong $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK $1 https://orcid.org/0000000254956425
700    1_
$a Bergstrom, Erik N $u Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA $u Department of Bioengineering, University of California San Diego, La Jolla, CA, USA $u Moores Cancer Center, University of California San Diego, La Jolla, CA, USA
700    1_
$a Khandekar, Azhar $u Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA $u Department of Bioengineering, University of California San Diego, La Jolla, CA, USA $u Moores Cancer Center, University of California San Diego, La Jolla, CA, USA
700    1_
$a Otlu, Burçak $u Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA $u Department of Bioengineering, University of California San Diego, La Jolla, CA, USA $u Moores Cancer Center, University of California San Diego, La Jolla, CA, USA $u Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey
700    1_
$a Cheema, Saamin $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK $1 https://orcid.org/0000000252972042
700    1_
$a Latimer, Calli $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK
700    1_
$a Thomas, Emily $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK
700    1_
$a Atkins, Joshua Ronald $u Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK
700    1_
$a Smith-Byrne, Karl $u Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK $1 https://orcid.org/0000000219327463
700    1_
$a Cortez Cardoso Penha, Ricardo $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Carreira, Christine $u Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Chopard, Priscilia $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Gaborieau, Valérie $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Keski-Rahkonen, Pekka $u Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France $1 https://orcid.org/0000000194373040
700    1_
$a Jones, David $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK $1 https://orcid.org/0000000204070386
700    1_
$a Teague, Jon W $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK
700    1_
$a Ferlicot, Sophie $u Service d'Anatomie Pathologique, Assistance Publique-Hôpitaux de Paris, Univeristé Paris-Saclay, Le Kremlin-Bicêtre, France
700    1_
$a Asgari, Mojgan $u Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran $u Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
700    1_
$a Sangkhathat, Surasak $u Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
700    1_
$a Attawettayanon, Worapat $u Division of Urology, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
700    1_
$a Świątkowska, Beata $u Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Łódź, Poland
700    1_
$a Jarmalaite, Sonata $u Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania $u Department of Botany and Genetics, Institute of Biosciences, Vilnius University, Vilnius, Lithuania
700    1_
$a Sabaliauskaite, Rasa $u Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania
700    1_
$a Shibata, Tatsuhiro $u Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan $u Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan
700    1_
$a Fukagawa, Akihiko $u Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan $u Department of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan
700    1_
$a Mates, Dana $u Occupational Health and Toxicology Department, National Center for Environmental Risk Monitoring, National Institute of Public Health, Bucharest, Romania
700    1_
$a Jinga, Viorel $u Urology Department, Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania
700    1_
$a Rascu, Stefan $u Urology Department, Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania
700    1_
$a Mijuskovic, Mirjana $u Clinic of Nephrology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia
700    1_
$a Savic, Slavisa $u Department of Urology, University Hospital Dr D. Misovic Clinical Center, Belgrade, Serbia $1 https://orcid.org/0000000236357437
700    1_
$a Milosavljevic, Sasa $u International Organization for Cancer Prevention and Research, Belgrade, Serbia
700    1_
$a Bartlett, John M S $u Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
700    1_
$a Albert, Monique $u Centre for Biodiversity Genomics, University of Guelph, Guelph, Ontario, Canada $u Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
700    1_
$a Phouthavongsy, Larry $u Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario, Canada $1 https://orcid.org/0009000768537233
700    1_
$a Ashton-Prolla, Patricia $u Experimental Research Center, Genomic Medicine Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil $u Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
700    1_
$a Botton, Mariana R $u Transplant Immunology and Personalized Medicine Unit, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil $1 https://orcid.org/0000000205099199
700    1_
$a Silva Neto, Brasil $u Service of Urology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil $u Post-Graduate Program in Medicine: Surgical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
700    1_
$a Bezerra, Stephania Martins $u Department of Anatomic Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil
700    1_
$a Curado, Maria Paula $u Department of Epidemiology, A. C. Camargo Cancer Center, São Paulo, Brazil
700    1_
$a Zequi, Stênio de Cássio $u Department of Urology, A. C. Camargo Cancer Center, São Paulo, Brazil $u National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, A.C. Camargo Cancer Center, São Paulo, Brazil $u Latin American Renal Cancer Group (LARCG), São Paulo, Brazil $u Department of Surgery, Division of Urology, Sao Paulo Federal University (UNIFESP), São Paulo, Brazil $1 https://orcid.org/0000000318978085
700    1_
$a Reis, Rui Manuel $u Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil $u Life and Health Sciences Research Institute (ICVS), School of Medicine, Minho University, Braga, Portugal
700    1_
$a Faria, Eliney Ferreira $u Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil $u Department of Urology, Barretos Cancer Hospital, Barretos, Brazil
700    1_
$a de Menezes, Nei Soares $u Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil
700    1_
$a Ferrari, Renata Spagnoli $u Department of Urology, Barretos Cancer Hospital, Barretos, Brazil
700    1_
$a Banks, Rosamonde E $u Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK $1 https://orcid.org/0000000200428715
700    1_
$a Vasudev, Naveen S $u Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK
700    1_
$a Zaridze, David $u Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia
700    1_
$a Mukeriya, Anush $u Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia
700    1_
$a Shangina, Oxana $u Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia
700    1_
$a Matveev, Vsevolod $u Department of Urology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia $1 https://orcid.org/0000000177489527
700    1_
$a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic $1 https://orcid.org/0000000304942620 $7 nlk20000084855
700    1_
$a Navratilova, Marie $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Holcatova, Ivana $u Institute of Public Health and Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Hornakova, Anna $u Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000210248056
700    1_
$a Janout, Vladimir $u Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
700    1_
$a Purdue, Mark P $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
700    1_
$a Rothman, Nathaniel $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
700    1_
$a Chanock, Stephen J $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA $1 https://orcid.org/0000000223243393
700    1_
$a Ueland, Per Magne $u Bevital AS, Bergen, Norway
700    1_
$a Johansson, Mattias $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a McKay, James $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Scelo, Ghislaine $u Observational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore
700    1_
$a Chanudet, Estelle $u Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands
700    1_
$a Humphreys, Laura $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK
700    1_
$a de Carvalho, Ana Carolina $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Perdomo, Sandra $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
700    1_
$a Alexandrov, Ludmil B $u Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA $u Department of Bioengineering, University of California San Diego, La Jolla, CA, USA $u Moores Cancer Center, University of California San Diego, La Jolla, CA, USA $1 https://orcid.org/0000000335964515
700    1_
$a Stratton, Michael R $u Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK $1 https://orcid.org/000000016035153X
700    1_
$a Brennan, Paul $u Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. brennanp@iarc.who.int $1 https://orcid.org/0000000205188714
773    0_
$w MED00003455 $t Nature $x 1476-4687 $g Roč. 629, č. 8013 (2024), s. 910-918
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38693263 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133511 $b ABA008
999    __
$a ok $b bmc $g 2143690 $s 1225926
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 629 $c 8013 $d 910-918 $e 20240501 $i 1476-4687 $m Nature $n Nature $x MED00003455
GRA    __
$p Wellcome Trust $2 United Kingdom
GRA    __
$a 001 $p World Health Organization $2 International
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...